Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis
Elisa Baratella, Barbara Ruaro, Fabiola Giudici, et al.
Diagnostics (2021) Vol. 11, Iss. 5, pp. 762-762
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Interstitial Lung Disease at High Resolution CT after SARS-CoV-2-Related Acute Respiratory Distress Syndrome According to Pulmonary Segmental Anatomy
Elisa Baratella, Barbara Ruaro, Cristina Marrocchio, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3985-3985
Open Access | Times Cited: 56
Research Progress in the Molecular Mechanisms, Therapeutic Targets, and Drug Development of Idiopathic Pulmonary Fibrosis
Hongbo Ma, Xuyi Wu, Yi Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
Barbara Ruaro, Andrea Salotti, Nicolò Reccardini, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 119-119
Open Access | Times Cited: 12
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
Barbara Ruaro, Riccardo Pozzan, Paola Confalonieri, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 8, pp. 1033-1033
Open Access | Times Cited: 38
Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis
Hongbo Ma, Shengming Liu, Shanrui Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Cellular Senescence: A Troy Horse in Pulmonary Fibrosis
Ruyan Wan, Lan Wang, Miaomiao Zhu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16410-16410
Open Access | Times Cited: 19
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
Barbara Ruaro, Elisa Baratella, Paola Confalonieri, et al.
Diagnostics (2021) Vol. 11, Iss. 11, pp. 1960-1960
Open Access | Times Cited: 34
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
Barbara Ruaro, Francesco Salton, Elisa Baratella, et al.
Diagnostics (2022) Vol. 12, Iss. 3, pp. 616-616
Open Access | Times Cited: 23
Glutamine Metabolism Is Required for Alveolar Regeneration during Lung Injury
Sisi Wang, Xue Li, Qingwen Ma, et al.
Biomolecules (2022) Vol. 12, Iss. 5, pp. 728-728
Open Access | Times Cited: 22
Amelioration of Pulmonary Fibrosis by Matrix Metalloproteinase-2 Overexpression
Ryo Inoue, Taro Yasuma, Valeria Fridman D’Alessandro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6695-6695
Open Access | Times Cited: 12
Genetic association analysis of dietary intake and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study
Chenwei Zhang, Yujia Xi, Yukai Zhang, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Olfactory mucosa mesenchymal stem cells alleviate pulmonary fibrosis via the immunomodulation and reduction of inflammation
Ran Duan, Chun‐Gu Hong, Xin Wang, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Radiological usual interstitial pneumonia pattern is associated with two-year mortality in patients with idiopathic pulmonary fibrosis
Ignacio Gayá García‐Manso, J.J. Arenas-Jiménez, Luis Blasco, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26623-e26623
Open Access | Times Cited: 4
MUC5B Polymorphism in Patients with Idiopathic Pulmonary Fibrosis—Does It Really Matter?
Katarzyna Lewandowska, Urszula Lechowicz, Adriana Roży, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2218-2218
Open Access
Telomere Dysfunction in Idiopathic Pulmonary Fibrosis
Kexiong Zhang, Lu Xu, Yu‐Sheng Cong
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 25
Circulating inflammatory cytokines and risk of idiopathic pulmonary fibrosis: a Mendelian randomization study
Qinyao Jia, Yan‐Mei Lei, Shaoping Chen, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Development of a Novel Biomarker for the Progression of Idiopathic Pulmonary Fibrosis
Hye Ju Yeo, Mihyang Ha, Dong Hoon Shin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 599-599
Open Access | Times Cited: 3
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Tongtong Xue, Qianyi Zhang, Tiantian Zhang, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis
Lichen Ouyang, Jie Gong, Muqing Yu
International Immunopharmacology (2021) Vol. 100, pp. 108145-108145
Open Access | Times Cited: 21
Angiotensin I-Converting Enzyme Inhibitory Activity of Two Peptides Derived from In Vitro Digestion Products of Pork Sausage with Partial Substitution of NaCl by KCl
Lifang Zou, Yu Zhou, Xia Yu, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 28, pp. 10638-10646
Closed Access | Times Cited: 9
Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
Reoto Takei, Toshiaki Matsuda, Jun Fukihara, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
High-Resolution Computed Tomography and Lung Ultrasound in Patients with Systemic Sclerosis: Which One to Choose?
Barbara Ruaro, Elisa Baratella, Paola Confalonieri, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2293-2293
Open Access | Times Cited: 18
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
Barbara Ruaro, Paola Confalonieri, Gaetano Caforio, et al.
Medicina (2022) Vol. 58, Iss. 8, pp. 1094-1094
Open Access | Times Cited: 13
Decoding the role of fatty acids and their metabolites in lung fibrosis
Małgorzata Wygrecka, Stefan Hadžić, Daniel P. Potaczek, et al.
Polskie Archiwum Medycyny Wewnętrznej (2023)
Open Access | Times Cited: 7
Prognostic Value of Serum Biomarkers in Patients with Idiopathic Pulmonary Fibrosis in Relation to Disease Progression
Kalliopi Domvri, Ioannis Organtzis, Apostolos Apostolopoulos, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1307-1307
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top